Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-24 @ 3:45 PM
NCT ID:
NCT04205292
Eligibility Criteria:
Inclusion Criteria:
* Singleton gestations;
* 18 years to 50 years;
* Diagnosis of CSP;
* Gestational age ≤ 8 weeks and 6 days;
* Therapy with systemic Methotrexate 2-dose;
* Thickness of myometrial layer ≥2 mm.
Exclusion Criteria:
* Diagnosis of cervical pregnancy, aborting intrauterine pregnancy, or any other anomalous implantation site;
* Gestational age \>8 weeks and 6 days;
* Heavy vaginal bleeding at the time of randomization;
* Women who did not received Methotrexate or received a single dose or a local dose;
* Thickness of myometrial layer \<2 mm
* Women who are unconscious, ill, mentally handicapped;
* Women under the age of 18 years or over the age of 50 years.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT04205292
Study Brief:
Protocol Section:
NCT04205292